Discoid Lupus in Dogs: Nose and Face Skin Lesions

By Emiel Maddens  ·  Reviewed in consultation with licensed veterinary professionals  ·  Updated June 2026  ·  10 min read

Photo by Tima Miroshnichenko on Pexels

Discoid lupus erythematosus (DLE) is the second most common autoimmune skin disease in dogs after pemphigus foliaceus. Unlike systemic lupus erythematosus, which can affect multiple organ systems, DLE is confined to the skin and does not typically involve the kidneys, joints, or other internal organs. The disease predominantly targets the nasal planum (the hairless, pigmented surface of the nose) and surrounding facial skin, causing depigmentation, loss of the normal textured surface, crusting, erosion, and ulceration.

DLE is a chronic condition that waxes and wanes, often worsening with UV exposure during sunny months and improving during winter. While it is not life-threatening, the cosmetic changes, discomfort, and risk of secondary complications, including squamous cell carcinoma in chronically UV-damaged depigmented tissue, make treatment important. Early recognition and appropriate management preserve nasal architecture, prevent scarring, and maintain quality of life.

This article covers the clinical presentation, breed predispositions, diagnostic approach, treatment options, and long-term management of discoid lupus in dogs.

Understanding Discoid Lupus Erythematosus

Pathophysiology

DLE is an immune-mediated disease in which autoantibodies and cell-mediated immune responses target the basal layer of the epidermis and the basement membrane zone. The exact trigger is unknown, but UV radiation is a well-documented exacerbating factor that induces keratinocyte apoptosis and exposes nuclear antigens to the immune system. The resulting inflammation at the dermo-epidermal junction causes basal cell damage, melanocyte destruction (producing depigmentation), and progressive tissue disruption. The nasal planum is particularly vulnerable because it lacks the protective hair coat and has chronic, direct UV exposure.

DLE vs Systemic Lupus Erythematosus

It is important to distinguish DLE from systemic lupus erythematosus (SLE), as the prognosis and treatment differ significantly. DLE is confined to the skin and does not cause systemic illness. Dogs with DLE have normal blood work, negative ANA (antinuclear antibody) tests in most cases, and no evidence of organ involvement. SLE, in contrast, is a multi-system disease that can affect the kidneys, joints, blood cells, and other organs. While SLE can include skin lesions similar to DLE, it also produces non-cutaneous signs such as joint pain, fever, proteinuria, and hemolytic anemia. Any dog with lupus-like skin lesions and systemic signs should be evaluated for SLE.

Relationship to UV Exposure

The link between UV radiation and DLE is well-established. UV-B rays damage keratinocytes, inducing apoptosis and exposing intracellular antigens to the immune system. In genetically predisposed dogs, this triggers an autoimmune response that attacks the basal epidermis. Clinically, DLE consistently worsens during summer months and in geographic regions with high UV exposure. Dogs living at higher altitudes or latitudes with intense sun have more severe disease. UV avoidance is therefore not just an adjunctive measure but a fundamental component of DLE management.

Clinical Signs and Affected Breeds

Classic Nasal Presentation

The earliest sign of DLE is loss of the normal cobblestone texture of the nasal planum, which becomes smooth and shiny. This is followed by depigmentation, changing from black to gray, then to pink. As the disease progresses, the depigmented tissue develops erythema, scaling, and crusting. In advanced cases, erosions and ulceration appear, and the nasal planum may become scarred and distorted. The lesions are typically symmetric, affecting both sides of the nose equally. Pain and tenderness are common, and some dogs resist having their nose touched.

Extension Beyond the Nose

While the nasal planum is the most common and often sole location, DLE can extend to adjacent structures. The dorsal muzzle, periocular skin, lips, and ear pinnae may develop similar depigmentation and crusting. In some dogs, the mucocutaneous junctions of the lips and eyelids are involved. Rarely, generalized DLE with lesions on the trunk and extremities has been reported. When lesions extend beyond the face, the differential diagnosis broadens and biopsy becomes even more important.

Breed Predispositions

Several breeds are overrepresented among DLE cases. German Shepherds, Siberian Huskies, Alaskan Malamutes, Collies, Shetland Sheepdogs, Brittany Spaniels, and German Shorthaired Pointers show increased incidence. The predisposition in northern breeds with heavily pigmented noses is notable, as the loss of pigment in these dogs is particularly conspicuous. Mixed-breed dogs can also develop DLE. No sex predisposition has been consistently identified.

Differentials That Mimic DLE

Several conditions can mimic the nasal depigmentation and crusting of DLE. Pemphigus foliaceus and erythematosus produce similar nasal lesions. Mucocutaneous pyoderma causes crusting at nasal and labial junctions. Vitiligo produces depigmentation without inflammation. Nasal hyperkeratosis causes thickening without the ulceration typical of DLE. Dermatophytosis and demodicosis can affect the face. Squamous cell carcinoma must be considered in any chronically depigmented, ulcerated nasal lesion. Biopsy is the only reliable way to distinguish these conditions definitively.

UV protection and consistent topical care are the foundations of discoid lupus management in dogs.

Photo by Alexander Mass on Unsplash

Diagnosis

Skin Biopsy and Histopathology

Definitive diagnosis of DLE requires punch biopsy from the affected nasal tissue with histopathological examination. The characteristic findings include interface dermatitis, a pattern of inflammation targeting the basal layer of the epidermis, with basal cell degeneration, pigmentary incontinence (melanin dropping into the dermis as melanocytes are destroyed), and a lymphoplasmacytic infiltrate at the dermo-epidermal junction. Thickening of the basement membrane zone may be apparent. These findings distinguish DLE from other causes of nasal depigmentation and crusting.

Immunohistochemistry and Immunofluorescence

Direct immunofluorescence testing on biopsy tissue can detect immunoglobulin and complement deposits at the basement membrane zone, providing additional diagnostic support. A positive lupus band test (immunoglobulin deposition at the dermo-epidermal junction) is consistent with DLE but is not always present, and false negatives can occur, especially if the biopsy is taken from a treated area. Immunohistochemistry can help characterize the inflammatory infiltrate and distinguish DLE from other interface dermatitis patterns.

Excluding Systemic Lupus

All dogs diagnosed with DLE should have basic blood work performed, including a complete blood count, serum chemistry, and urinalysis, to ensure there is no evidence of systemic disease. An ANA test is typically negative in DLE but may be weakly positive in some cases. If the ANA is positive, or if there are any non-cutaneous signs, further evaluation for SLE, including assessment of kidney function, joint examination, and potentially additional serological testing, is warranted.

Treatment Options

Sun Avoidance and UV Protection

UV protection is the foundation of DLE management and should be implemented in every case regardless of severity. Limit outdoor time during peak UV hours (10 AM to 4 PM), provide shaded areas for outdoor rest, and apply pet-safe sunscreen with SPF 30 or higher to the nose and affected facial skin before any sun exposure. Titanium dioxide or zinc oxide-based sunscreens are preferred because they provide physical UV blocking and are generally well-tolerated, although ingestion of zinc oxide should be prevented. Some owners use UV-protective nose balms that combine sun protection with moisturizing.

Topical Therapy for Mild Cases

Mild DLE limited to depigmentation and minimal crusting may respond to topical therapy alone. Topical tacrolimus (0.1 percent) is the most commonly used and effective topical immunomodulator for DLE. It is applied to the affected area twice daily and produces improvement in two to four weeks in most responsive cases. Topical glucocorticoids can also be used but carry a risk of skin atrophy with prolonged application, particularly on the delicate nasal tissue. Vitamin E applied topically has antioxidant properties that may provide modest benefit as an adjunctive treatment.

Systemic Therapy for Moderate to Severe Cases

Dogs with progressive ulceration, pain, or failure to respond to topical therapy require systemic treatment. The combination of tetracycline (or doxycycline) and niacinamide (vitamin B3) is often used as a first-line systemic therapy for DLE because these drugs have immunomodulatory effects with fewer side effects than glucocorticoids. The typical dose is doxycycline at 5 mg/kg twice daily combined with niacinamide at 250 mg three times daily for dogs under 10 kg or 500 mg three times daily for larger dogs. Response is typically seen within two to three months. If this combination is insufficient, low-dose glucocorticoids may be added.

Severe or Refractory Cases

Dogs that fail to respond to doxycycline/niacinamide and topical tacrolimus may require immunosuppressive therapy with glucocorticoids, azathioprine, mycophenolate mofetil, or cyclosporine. These cases should ideally be managed by a veterinary dermatologist who can tailor the immunosuppressive regimen to the individual patient and monitor for side effects. The goal is to achieve the minimum effective level of immunosuppression that controls the disease while minimizing adverse drug effects.

Long-Term Management and Prognosis

Disease Course and Remission

DLE is a chronic condition that requires lifelong management in most cases. The disease follows a waxing and waning course, with flares typically occurring during sunny months and improvement during winter. Some dogs achieve good long-term control with topical therapy and sun avoidance alone. Others require ongoing systemic treatment. True drug-free remission is uncommon, occurring in an estimated 10 to 15 percent of dogs. Most dogs can achieve a good quality of life with consistent treatment and UV protection.

Monitoring for Complications

The most serious long-term complication of DLE is the development of squamous cell carcinoma in chronically depigmented, UV-damaged nasal tissue. While this complication is uncommon with appropriate management, any new or changing ulcerative lesion that does not respond to treatment should be biopsied to rule out neoplastic transformation. Regular veterinary examinations, ideally every three to six months, allow monitoring of disease activity and early detection of any suspicious changes.

Impact on Quality of Life

Most dogs with well-managed DLE lead normal, comfortable lives. The nasal depigmentation is primarily a cosmetic concern, and with appropriate treatment, ulceration and pain can be controlled. The main impacts on daily life are the need for sun avoidance, which may limit outdoor activities during peak UV hours, and the daily application of topical medications or sunscreen. Owners of affected dogs should be reassured that the condition is manageable and that their dog's overall health and lifespan are not typically affected.

Practical Tips for Owners

Daily Nose Care Routine

Establish a twice-daily routine of gentle cleaning and medication application. Use a soft cloth dampened with warm water to remove crusts from the nasal planum, being careful not to cause pain or bleeding. Apply prescribed topical medication (tacrolimus or glucocorticoid) to the clean, dry surface. If the dog will be going outdoors, apply sunscreen over the medication once it has been absorbed. Consistency is key, as missing applications allows the disease to flare.

Managing Outdoor Time

Plan walks and outdoor activities for early morning or late evening when UV intensity is lowest. If outdoor time during peak hours is unavoidable, apply sunscreen to the nose and any other affected areas and seek shaded routes. Consider a UV-protective nose guard or visor for dogs that spend extended time outdoors. Monitor the UV index through weather apps and adjust outdoor plans accordingly. Most owners find that their DLE-affected dogs adapt well to modified outdoor schedules.

Seasonal Adjustments

Expect the disease to require more aggressive management during summer and less during winter. Your veterinarian may recommend increasing medication during high-UV months and tapering slightly during low-UV months. Keep a simple diary of nasal appearance, medication doses, and UV exposure to identify your dog's individual pattern and adjust proactively rather than reactively. Photos of the nose taken at regular intervals provide an objective record of disease activity over time.

Discoid Lupus in Dogs FAQ

Q: What is discoid lupus in dogs?

Discoid lupus erythematosus (DLE) is an autoimmune skin disease that primarily affects the nose and face. The immune system attacks the basal layer of the epidermis, causing depigmentation, loss of the normal cobblestone texture of the nose, crusting, erosions, and in severe cases, ulceration. It is the second most common autoimmune skin disease in dogs.

Q: Is discoid lupus the same as systemic lupus?

No. DLE is confined to the skin and does not affect internal organs. Systemic lupus erythematosus (SLE) is a multi-system disease that can involve the kidneys, joints, blood cells, and other organs in addition to the skin. DLE has a much better prognosis than SLE. However, any dog with lupus-like skin lesions and systemic signs should be evaluated for SLE.

Q: Does sunlight make discoid lupus worse?

Yes, UV radiation is a well-documented trigger for DLE flares. UV-B rays damage keratinocytes, exposing nuclear antigens and stimulating the autoimmune response. DLE consistently worsens during sunny months and improves during winter. Sun avoidance and application of pet-safe sunscreen are essential components of DLE management.

Q: Which breeds are most likely to get discoid lupus?

German Shepherds, Siberian Huskies, Alaskan Malamutes, Collies, Shetland Sheepdogs, Brittany Spaniels, and German Shorthaired Pointers are overrepresented among DLE cases. However, any breed, including mixed breeds, can develop the condition. There is no consistent sex predisposition.

Q: Can discoid lupus be cured?

DLE is a chronic condition that typically requires lifelong management. True drug-free remission occurs in approximately 10 to 15 percent of dogs. Most dogs need ongoing treatment with topical medications, sun avoidance, and sometimes systemic immunomodulatory therapy. With consistent management, most dogs maintain good quality of life and normal lifespan.

Sources

Olivry, T., et al. (2015). Treatment of canine DLE with tetracycline and niacinamide. Veterinary Dermatology, 26(2), 124-e27.

Wiemelt, S.P., et al. (2004). Tumors of the skin and soft tissues. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th ed.

Scott, D.W., Miller, W.H., & Griffin, C.E. (2001). Small Animal Dermatology, 6th Edition. W.B. Saunders.

Mueller, R.S., et al. (2019). Diagnosis of canine DLE and pemphigus: histological and immunopathological findings. Veterinary Pathology, 56(1), 50-62.

Banovic, F. (2019). Discoid lupus erythematosus in dogs: an update. Veterinary Dermatology, 30(4), 278-e83.

Related Reading

• Pemphigus in Dogs, The most common autoimmune blistering skin disease in dogs
• Nasal Hyperkeratosis in Dogs, Dry, cracked nose tissue and how to manage it
• When to See a Veterinary Dermatologist, Complex autoimmune conditions that benefit from specialist care
• Senior Dog Skin Problems, Age-related skin changes including immune-mediated conditions

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.